Showing results (141-150 of 150) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
European Urology Focus|February 2, 2021
The Benefits and Harms of Botulinum Toxin-A in the Treatment of Chronic Pelvic Pain Syndromes: A Systematic Review by the European Association of Urology Chronic Pelvic Pain PanelBrian A Parsons, Sanchia Goonewardene, Saeed Dabestani, et al.Journal of Medicinal Chemistry|April 10, 2024
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with <i>MTAP</i>-Deleted CancersKevin M Cottrell, Kimberly J Briggs, Douglas A Whittington, et al.Journal of Medicinal Chemistry|June 30, 2015
Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γPhilip N Collier, David Messersmith, Arnaud Le Tiran, et al.Scientific Reports|April 27, 2026
Site-specific variation and non-indigenous species detection in Arabian Gulf biofouling communities using DNA metabarcoding and photographic surveysSahar Chebaane, Eva Aylagas, Juan Sempere-Valverde, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b InhibitorsSimon Giroux, Jinwang Xu, T Jagadeeswar Reddy, et al.Bioorganic & Medicinal Chemistry Letters|January 18, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 1: C2-symmetric inhibitors with diyne and biphenyl linkersSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.Bioorganic & Medicinal Chemistry Letters|January 19, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 2: non-symmetric inhibitors with potent activity against genotype 1a and 1bSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Inhibitors of hepatitis C virus NS3.4A protease. Part 3: P2 proline variantsRobert B Perni, Luc J Farmer, Kevin M Cottrell, et al.Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Synthesis and evaluation of NS5A inhibitors containing diverse heteroaromatic coresJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Benzimidazole-containing HCV NS5A inhibitors: effect of 4-substituted pyrrolidines in balancing genotype 1a and 1b potencyJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.Pageof 15